Skip to main content

Table 2 Baseline clinical characteristic of enrolled 35 patients

From: Assessment of left ventricular diastolic function after Transcatheter aortic valve implantation in aortic stenosis patients by echocardiographic according to different guidelines

Demographic data

 Agea (year)

79.6 ± 4.3 (72–87)

 Femaleb n (%)

15 (42.9)

 BMIa (kg/m2)

22.9 ± 3.72

 Body surface areaa (m2)

1.68 ± 0.18

 Heart ratea (beats/min)

69.1 ± 10.8

 Systolic BPa (mmHg±SD)

134.5 ± 2.9

 Diastolic BPa (mmHg±SD)

65.7 ± 11.5

 Hemoglobina (g/L ± SD)

114.6 ± 11.3

 Creatininea (mmol/L ± SD)

81.5 ± 21.3

 STS scorea (%mortality±SD)

8.8 ± 4.2

 EuroSCOREa

3.6 ± 1.9

Artificial aortic valveb n (%)

 Medtronic Hancock II

1(2.9)

 VENUS-A

23 (65.7)

 J-Valve

11 (31.4)

Medical historyb n (%)

 Hypertension

17 (48.6)

 Diabetes

9(25.7)

 Coronary heart disease (CHD)

14 (40)

 Previous PCI

3 (8.5)

 COPD

6 (17.1)

Degree of mitral regurgitationb n (%)

 None/Mild

22 (62.9)/13 (37.1)

 Mitral annular calcification n (%)

17 (48.6)

NYHA functional classificationb n (%)

 I/II/III/IV

0/8 (22.9)/24 (68.6)/3 (8.5)

Diastolic dysfunctionb n (%)

Normal/I/II/ III/Indeterminate

7 (20)/7 (20)/14 (40)/5 (14)/2 (6)

  1. BP blood pressure; STS society of thoracic surgeons; PCI percutaneous coronary intervention; COPD chronic obstructive pulmonary disease; NYHA New York Heart Association;
  2. aData are mean ± SD with range in parentheses
  3. bData are raw number with percentage in parentheses